AUG 29, 2015 2:18 PM PDT

Virus Causes Liver Cancer

WRITTEN BY: Ilene Schneider
Viruses can be involved in the development of serious diseases. A case in point is liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. 
Liver cancer is usually found in already damaged cells.
Researchers at Inserm, the Paris Public Hospitals (AP-HP), Paris Descartes University, Paris 13 University (USPC) and Paris Diderot University have identified the role of a new virus in a rare type of liver cancer. This study, based on follow-up and observation of 193 patients, is published in Nature Genetics and reported in Drug Discovery & Development

More than 8,000 new individuals are diagnosed with liver cancer every year. It mainly affects men and is a major cause of death worldwide. Of the different types, hepatocellular carcinoma usually occurs in a liver already damaged by illness. The liver may have been weakened by excessive alcohol consumption, obesity or chronic viral infection by hepatitis B or C viruses, causing irreversible liver lesions, ultimately culminating in cirrhosis.

While cirrhosis patients usually undergo regular tests to detect cancer, in 5 percent of cases, liver cancer occurs in patients who had not reported cirrhosis. Thus, the reason for developing the cancer is a mystery. Jessica Zucman-Rossi and her staff at Inserm Unit 1162, Functional Genomics of Solid Tumors, took a special interest in these patients to discover the risk factors that had contributed to the development of their cancer.

According to the report, “In the genome of tumor cells of 11 patients, the scientists observed the insertion of a viral DNA segment from adeno-associated virus type 2, known as AAV2. This virus has been considered non-pathogenic for humans until now. In order to confirm the virus's involvement in the cancer, the research team compared tumor tissues with normal tissues. They thus confirmed their hypothesis: the integration of viral DNA was found more often in tumor cells than in healthy cells in these 11 patients. Moreover, eight of these patients did not have cirrhosis, and six of them presented no known risk factors for liver cancer.

When they studied these malignant cells in greater detail, the researchers discovered that the virus, when putting its DNA into the genome of the patient's cells, targets genes important in cell proliferation. The researchers have demonstrated that AAV2 leads to excessive expression of these genes that may cause tumor development.

In this work, the researchers have identified the involvement of AAV2 virus, which used to be considered harmless, in the occurrence of hepatocellular carcinoma, especially in the rare cases of cancer that develop without cirrhosis or another identified cause. The researchers caution, "AAV2 is often used as a vector in gene therapy. Although the insertion of its DNA into tumor promoting genes is rare, and probably a chance event, precautions must be taken regarding the use of this virus."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 13, 2020
Cancer
Should we be treating kidney cancer differently?
SEP 13, 2020
Should we be treating kidney cancer differently?
New research published in the journal Clinical Cancer Research is questioning how we treat kidney tumors. According ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 14, 2020
Cancer
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
OCT 14, 2020
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
Cold atmospheric plasma is a relatively new technique that utilizes a tool that generates a sort of plasma scalpel, exce ...
OCT 14, 2020
Cancer
Research suggests statins could reduce the risk of cancer
OCT 14, 2020
Research suggests statins could reduce the risk of cancer
New research published in the journal eLife provides evidence that statins, the common cholesterol-lowering drugs, could ...
OCT 26, 2020
Chemistry & Physics
Fighting mesothelioma with gold nanotubes
OCT 26, 2020
Fighting mesothelioma with gold nanotubes
New research published in the journal Small details how gold nanotubes could be used to treat mesothelioma cancer. ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
Loading Comments...